We report the first clinical use of PEG-modified Arthrobacter protoformiae uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin lymphoma and renal insufficiency
lymphoma (NHL) and acute lymphoblastic leukemia (ALL).
"Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia / Non-Hodgkin lenfoma ve akut lenfoblastik losemili cocuklarda
Non-Hodgkin lymphomas are malignant lymphomas that are not classified as Hodgkin's disease.
Non-Hodgkin lymphoma Other names Non-Hodgkin disease Micrograph of mantle cell lymphoma, a type of non-Hodgkin lymphoma. Terminal ileum. H&E stain.
Non-Hodgkin's Lymphoma: Diagnosis Non-Hodgkin's Lymphoma: Treatment Non-Hodgkin's Lymphoma Incidence (frequency) Non-Hodgkin's lymphoma survival rate
IVB Hodgkin's lymphoma).
Purpose: Hyperuricemia and tumor lysis syndrome are well-known complications during induction treatment of aggressive non-Hodgkin’s lymphomas (NHLs).
We retrospectively evaluated the efficacy of febuxostat 10 mg in prevention of hyperuricemia associated with TLS (HU-TLS) in 12 patients with non-Hodgkin's lymphoma (NHL).
This dermatologic entity cleared after the treatment for Hodgkin lymphoma, suggesting a true paraneoplastic reaction.
Patients in whom erythema nodosum was associated with non-Hodgkin lymphoma had an extremely protracted course.
Erythema nodosum associated with non-Hodgkin lymphoma may precede the diagnosis of lymphoma by months.
The ICD code for Hodgkin lymphoma is ICD-10 C81.
Diagnosing Hodgkin lymphoma More information about Hodgkin lymphoma treatment Treatment for Hodgkin lymphoma includes chemotherapy, radiotherapy, steroids, targeted therapies
What causes non-Hodgkin lymphoma? The exact cause of non-Hodgkin lymphoma is unknown.
Abstract Background: The occurrence of autoimmune hemolytic anemia (AIHA) in patients with non-Hodgkin's lymphoma (NHL) is well known.
The patients with refractory Hodgkin lymphoma have a poor prognosis.
It is often associated with other autoimmune disorders, immunodeficiencies, and non-Hodgkin's lymphoma.
Abstract Three out of 140 patients with non-hodgkin's lymphoma treated in a Department of Internal Medicine showed hypercalcemia during their clinical course.
Angioimmunoblastic T cell lymphoma is a rare malignancy, accounting for only 2% of all non-Hodgkin lymphomas, first described in the 1970s and subsequently accepted as a distinct
and iii) Increased production of 1,25 dihydroxyvitamin D by tumors – Hodgkins and some non-Hodgkins lymphoma.
Lung cancer, usually small cell carcinoma, comprises 75-80% of these cases and non-Hodgkin lymphoma, most commonly diffuse large B-cell lymphoma, comprises 10-15%.
Overall response rate was as follows: Hodgkin's disease 100 %, non-Hodgkin's lymphoma 29 %, SCLC 22.8 %, non-small cell lung cancer 9.6 % and metastatic cancer 16.6 %.
Small cell lung cancer and non-Hodgkin lymphoma are the most frequent culprits. Intravascular devices associated with thrombus are becoming more common causes.
Further CT-guided biopsy was performed and non-Hodgkin lymphoma was diagnosed based on pathological results.
/ [Radiologic diagnosis of non-Hodgkin's lymphoma in abdominal and retroperitoneal sites].
[…] with an estimated annual incidence of 1/100,000 in Western countries. [ 5 ] Extranodal marginal zone lymphomas of MALT type represent about 7% of all non-Hodgkin's lymphomas
In this report, we present an unusual case of PML occurring 40years after chemoradiation therapy for Hodgkin lymphoma in a patient with normal total lymphocyte counts on annual
A 66-year-old man with non-Hodgkin lymphoma (NHL) developed progressive multifocal leukoencephalopathy (PML) after undergoing chemotherapy including rituximab.
We describe an unusual case of PML in a 54-year-old patient with follicular non-Hodgkin lymphoma who received rituximab plus cyclophosphamide, hydroxydaunorubicin, oncovicin
Introduction Primary pulmonary Hodgkin lymphoma (PPHL) is a rare disease.
Abstract Background: Primary pulmonary non-Hodgkin's lymphoma is a very rare neoplasm.
We hereby present two such cases of pulmonary Hodgkin’s lymphoma diagnosed on histopathology.
(PCNSL) represents a rare subtype of non-Hodgkin lymphoma (NHL) restricted to the CNS.
Hodgkin lymphoma within the brain.
Primary central nervous system lymphoma (PCNSL) is an uncommon form of non-Hodgkin lymphoma affecting the brain, spinal cord, and leptomeninges.
We report a 30-year-old man with Hodgkin's lymphoma who developed acute polymyositis following treatment by DLI 4 months post-allogeneic HSCT.
The specific malignancies associated with polymyositis are lung cancer, nasopharyngeal cancer and non-Hodgkins lymphoma.
Other less frequently reported neoplasms include colorectal cancer, and non-Hodgkin lymphoma, pancreatic, gastric, and bladder cancer (see these terms).
Non-Hodgkin's lymphomas (NHLs) are a heterogeneous group of lymphoproliferative malignancies that may be associated with acquired immunodeficiency syndrome (AIDS).
Kaposi’s sarcoma HIV-infection AIDS Non-Hodgkin’s lymphoma Hodgkin’s lymphoma Multiple myeloma Antiretroviral therapy © AlphaMed Press doi: 10.1634/theoncologist.10-6-412
This report presents and discusses two unusual cases of gingival primary extranodal non-Hodgkin's lymphoma (PE-NHL) as the first manifestation of AIDS.
CONCLUSIONS: This study confirms an increased risk of cancer, especially non-Hodgkin's lymphoma, probably attributable to defective immunity, among patients with CHH.
KEYWORDS: RMRP ; immunodeficiency; non-Hodgkin lymphoma; short stature; skeletal dysplasia
Five patients (38%) with CHH and HD had died; 4 of enterocolitis-related septic infection and one of non-Hodgkin's lymphoma.
" - Source PubMed Source- Splenectomy in patients with malignant non-Hodgkin's lymphoma. Eur J Haematol. 2000 Mar;64(3):145-50.
Splenectomised patients with Hodgkin lymphoma had significant lower numbers of T lymphocytes than trauma patients.
Among the 29 patients, 7 cases were non-Hodgkin lymphomas based on spleen pathology, 1 case withdrew and the remaining 21 non-lymphoma cases were available for analysis.
We describe a case of pulmonary infection with Nocardia asteroides in a non-Hodgkin's lymphoma patient.
non-Hodgkins lymphoma, glioblastoma multiforme [if ocular involvement]); (9) Kaposi's sarcoma; (10) yaws The differential for pulmonary or disseminated nocardiosis includes
mycobacteria (cutaneous tuberculosis, Mycobacterium marinum, Mycobacterium avium complex); (8) other bacterial and fungal causes of mycetomas; (9) neoplasms (cutaneous lymphomas
Physical factors: radiotherapy, cold, sunlight Others: collagen diseases, vasculitides, non-Hodgkin lymphoma, leukaemia, multiple myeloma, myeloid metaplasia, polycythemia
lymphoma, leukemia, multiple myeloma, myeloid metaplasia, and polycythemia Physical or mechanical factors, such as tattooing, radiotherapy, cold, and sunlight Foods, including
[…] such as benzoic acid and cinnamon  Immunologic disorders, such as transient selective C4 deficiency of infancy,  collagen diseases, vasculitides, sarcoidosis, non-Hodgkin
Polymyositis was associated with a raised risk of non-Hodgkin lymphoma (3.7, 1.7-8.2), and lung (2.8, 1.8-4.4) and bladder cancers (2.4, 1.3-4.7).
Rituximab is indicated for the treatment of patients with relapsed or refractory, low-grade or follicular, CD20-positive, B-cell non-Hodgkin lymphoma.
Other less frequently reported neoplasms include colorectal cancer, or non-Hodgkin lymphoma, pancreatic, gastric and bladder cancer (see these terms).
We present a case of herpes zoster eruption occurring after PDT for actinic keratoses in a patient with Non-Hodgkin Lymphoma (NHL).
lymphoma b 11 3.8 1.9–6.7 Hodgkin's lymphoma 0 — — Multiple myeloma 8 4.8 2.1–9.4 Leukaemia 10 2.8 1.3–5.1 Immune-related cancers 32 1.1 0.8–1.6 Liver 3 1.5 0.4–6.0 Cervix
Diseases such as AIDS or Hodgkin lymphoma Chemotherapy or radiation therapy Certain medicines, such as steroids Your risk for getting shingles may be higher if you have recently
[…] s lymphoma and in 10% of patients with non-Hodgkin?
lymphoma QUANTIFERON TB GOLD -whole blood testing looking for interferon gamma -advantages: quick test, just blood draw, not affected by vaccine, develops in the course of
[…] s lymphoma.16 The radiographic manifestations of lymphoma in the lung are protean; however, hilar or mediastinal lymphadenopathy is almost always seen in patients with Hodgkin
It can occur alone or in association with other diseases e.g. multiple myeloma, Waldenstrom’s macroglobulinaemia, or non-Hodgkin’s lymphoma.
lymphoma Renal cell carcinoma Chronic foreign body reaction HIV/AIDS Silicone-induced granulomatous reaction Pathology In a healthy individual, the median
Myelodysplastic Syndromes Myeloproliferative Neoplasms Neuroendocrine and Adrenal Tumors Non-Hodgkin's Lymphomas Primary Cutaneous Lymphomas Non-Melanoma Skin Cancers Dermatofibrosarcoma
Microcytic anemia (MCV < 82 fL) IDA Thalassemia Non thalassemic conditions associated with microcytosis ACD (e.g. rheumatoid arthritis, Hodgkin’s lymphoma, chronic infection
’s lymphoma, chronic infection, neoplasia) Sideroblastic anemia (e.g. hereditary, lead poisoning) Normocytic anemia (MCV = 82-98 fL) Nutritional anemia (iron deficiency, cobalamin
Table 2 Morphological classification Microcytic anemia (MCV < 82 fL) IDA Thalassemia Non thalassemic conditions associated with microcytosis ACD (e.g. rheumatoid arthritis, Hodgkin
Junca J, Cuxart A, Tural C, Ojanguren I, Flores A: Eosinophilic fasciitis and non-Hodgkin lymphoma. Eur J Haematol 1994;52:304–306.
Only a few cases of EF have been previously described preceding or concomitant to the Hodgkin disease, peripheral T-cell lymphoma, B-cell lymphoma, and mycosis fungoides.
Patrizi A, Di Lernia V, Neri I, Gherlinzoni F (1992) Eosinophilic pustular folliculitis (Ofuji’s disease) and non-Hodgkin lymphoma.
57 Osteoporosis is a potentially preventable complication of SLE. 57 The incidence of non-Hodgkin lymphoma is increased three- to fourfold compared with the general population
lymphoma ). [ 9 ] Management Patients often require considerable counselling about their individual prognosis and symptoms.
lymphoma and lung cancer)    Infections Hypertension Dyslipidemia Diabetes Mellitus Osteoporosis Avascular Necrosis  Medications Analgesics  : These medications
Systemic AL amyloidosis due to non-Hodgkin's lymphoma: an unusual clinicopathologic association.
lymphoma, Waldenström's macroglobulinemia and multiple myeloma (MM).
Although AL amyloidosis typically is viewed as a rare disease, its incidence is similar to that of Hodgkin’s lymphoma or chronic myelogenous leukemia ( 2 ).
We report a case of a 54-year-old man survivor of Hodgkin lymphoma (HL), who developed DHS 28 years after radiotherapy.
T02-11 Media Inquiries: 301-827-6242 February 19, 2002 Consumer Inquiries: 888-INFO-FDA FDA APPROVES FIRST RADIOPHARMACEUTICAL PRODUCT TO TREAT NON-HODGKIN’S LYMPHOMA FDA
INTRODUCTION: Hodgkin lymphoma (HL) is one of the most common types of cancers of the lymphatic system.
Abstract We present images of a 50-year-old man who referred for treatment of a classic Hodgkin lymphoma.
Primary bilateral non-Hodgkin's lymphoma of the adrenal gland is a rare presentation with <200 reported cases.
Paraneoplastic myelitis : Hodgkin lymphoma Postradiation myelopathy : The syndrome of delayed radiation-induced myelopathy has bimodal incidence, with peaks at 12-14 months
For some time Cope’s diagnosis was widely accepted, but in 1997 Claire Tomalin put forth the possibility of a “lymphoma such as Hodgkin’s disease—a form of cancer” (283),